NVO - Structure Therapeutics stock tanks amid Phase 2 obesity drug data
2023-12-18 12:47:56 ET
More on Structure Therapeutics
- Structure Therapeutics: Tipping The Scales In Obesity Management
- Pfizer hits new 52-week low after weight loss setback
- Leerink sees Structure Therapeutics stock as "undervalued"
- Historical earnings data for Structure Therapeutics
- Financial information for Structure Therapeutics
For further details see:
Structure Therapeutics stock tanks amid Phase 2 obesity drug data